Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests ...

The diagnosis of a suspected lung, head, and neck cancer called NUT carcinoma should include additional testing capable of detecting gene fusions that are definitive markers of the disease, according ...

The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor ...

NANJING, China, July 25, 2025 /PRNewswire/ -- On 25 July, 2025 (China Time), Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" ...

FURVENT is a global, pivotal 3 arm Phase 3 clinical trial of firmonertinib in first-line non-squamous locally advanced or metastatic NSCLC patients with exon 20 insertion mutations being conducted ...

The results from a prospective, multicentre cohort study from using a national registry of targeted therapies investigating cancer (excluding non-melanoma skin cancer [NMSC]) and NMSC (basal cell ...

Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor ...

Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with particularly high prevalence in East Asia. While ...

Older women with vulvar lichen sclerosus are more likely to develop a common type of vulvar cancer if left untreated but are likely underdiagnosed, suggesting that more counseling and regular skin ...

A new study of female Medicare beneficiaries reveals that vulvar lichen sclerosus affects 7 out of every 1,000 women aged 65 and older, significantly higher than rates seen in younger populations. The ...

NANJING, China, July 24, 2025 /PRNewswire/ — On 25 July, 2025 (China Time), Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company”) listed on the Main Board of The Stock Exchange of Hong ...